While forecasts can never be 100% accurate, the goal for biopharmaceutical forecasters should be to minimize the degree of inaccuracies as much as possible. To reduce the impact of inaccurate forecasting over the life cycle of a product, companies need to focus on those variables that they have the most control over.
With the ever evolving developments in the biopharmaceutical Industry there has never been a greater need for assured Reliability when it comes to the transportation of Pharmaceutical payloads and the guaranteed robustness of Temperature-controlled packaging is proving ever more vital.
Your cold chain is about more than just protecting and delivering temperature-sensitive products. It is about caring for the lives affected by those products and protecting the environment we all share. Although many organizations still consider it challenging to find a packaging solution that is sustainable, affordable and operationally efficient for cold chain distribution, Cardinal Health knows differently.
The expanding global pharmaceutical industry projects a 4%-6% annual growth and forecasts that it will reach a value of $1T by 2014. By Paul Dupont
Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. In 2010, blister represented 17% of the global market and recorded $8.1B in revenue, according to Pharmaceutical Packaging Industry – 2011 Yearbook. GBI Research. By Paul Dupont, Director of Business Development North America, Ropack, Inc.
Volumetric feeders control flow by discharging a consistent volume of material. They are best used when bulk density is consistent, long term feed accuracy is not critical, and feeder performance does not need to be documented. By Sharon Nowak
Audits by the Food and Drug Administration (FDA), historically a source of angst, may be generating even more concern. Recently, the FDA has escalated its cGMP compliance inspections by enforcing increasingly complex regulations, gaining greater access to records and conducting audits more frequently – up from .06 to .09 per year, according to Bloomberg News. By Paul Dupont, Ropack
With over four decades of commercial pharmaceutical packaging expertise and in excess of 50 successful product launches per year, PCI is a trusted leader and industry expert in the commercialization of new medicines.
Patient safety and product integrity begins with strategic approach in providing pharmaceutical and biotech products through a safe and secure supply chain.
At PCI we combine knowledge, experience, and innovative technologies to provide our customers packaging services that ensure safety and reliability throughout.
Ropack recognizes that the unique design of stick-pack offers multiple benefits – for pharma and natural health products as well as to consumers.
Ropack Pharma Solutions provides encapsulation services for commercial pharmaceutical and natural health products as well as over-encapsulation for clinical application. Our hard gelatin fillers are designed specifically for powder filling and can accommodate capsule sizes from 3 through 00. Clinical over-encapsulation adjusts for such potential discrepancies as weight, sound and visual differences.
